Integrated traditional Chinese and Western medicine versus Western medicine in treatment of arteriosclerosis obliterans: A systematic review of randomized controlled trials

Journal of Chinese Integrative Medicine

Volumn 8, Issue 10, 2010, Pages 917-927

  You, Xue Mei ^a   Qin, Xiao ^a   Dong, Zhi Yong ^b   Wang, Guan Liang ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arteriosclerosis obliterans; Integrated traditional Chinese and Western medicine; Meta analysis; Systematic review

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

AMPUTATION; ANKLE BRACHIAL INDEX; AUTHOR; CHINESE MEDICINE; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROL GROUP; DATA EXTRACTION; DATA SYNTHESIS; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SCREENING; HUMAN; INTEGRATIVE MEDICINE; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; META ANALYSIS; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY CONTROL; REVIEW; RISK FACTOR; SAFETY; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE; WESTERN MEDICINE;

ARTERIOSCLEROSIS OBLITERANS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78049518678     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20101003     Document Type: Review

References (30)

1. Vascular Surgery Group of Surgery Branch of Chinese Medical Association. Guideline for treatment of lower extremity arteriosclerosis obliterans. Zhongguo Shi Yong Wai Ke Za Zhi. 2008; 28(11): 923-924
2. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg. 2000; 19(Suppl A): Si-xxviii, S1-250.
3. Ouriel K. Peripheral arterial disease. Lancet. 2001; 358(9289): 1257-1264.
4. Clement DL. Medical treatment of peripheral artery occlusive disease (PAOD). Acta Chir Belg. 2000; 100(5): 190-193.
5. Paumier A, Abraham P, Mahé G, Maugin E, Enon B, Leftheriotis G, Picquet J. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2010; 39(3): 323-329.
6. Steg PG, Tanlil O, Aubailly N, Caillaud JM, Dedieu JF, Berthelot K, Roux AL, Feldman L, Perricaudet M, Denèfle P, Branellec D. Reduction of restenosis after angioplasty in an atheromatous. Circulation. 1997; 96(2): 408-411.
7. Shang DJ, Wang JJ, Zhang BG. Peripheral vascular surgery of integrated traditonal Chinese and Western medicine. Beijing: People's Medical Publishing House. 2004: 272-274.
8. Tian DL. Traditional Chinese internal medicine. Beijing: People's Medical Publishing House. 2002: 168-170.
9. Hou YF, Chen BN, Zhou T, Jin X, Zhou LL, Qin HS, Liu CM, Li ZH, Han QC, Liu M, Liu HP, Zhao XD. Clinical research on arteriosclerosis obliterans treated by Mairong Mixtrure. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 1999; 5(2): 70.
10. Dong JS, Wang CX, Hang LN, Wu XZ. Observation on effect of integrated Chinese and Western medicine treatment in patients with atherosclerosis obliterans. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 1999; 5(3): 133-136.
11. Cui GR. Necessity and feasibility of integrated traditional Chinese and Western medicine therapy in treatment of arteriosclerosis obliterans. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 2005; 11(2): 91-92. .
12. Committee of Peripheral Vascular Disease, China Society of Integrated Traditional Chinese and Western Medicine. Criteria for diagnosis and therapeutic effect evaluation of peripheral vascular diseases. Fuzhou: The Fourth National Integrated Chinese and Western Medicine Treatment of Vascular Diseases: Academic Conference Proceedings. 1995: 10.
13. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5. 0. 1 [updated September 2008]. http://www.cochrane- handbook.org/.
14. Li LG, Xu H, Zhao G, Wu MY, Li RH. Kangmai Injection combined with Western medicine in treatment of 92 cases of arteriosclerosis obliterans. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003; 23(7): 555.
15. Zhao F. Integrated traditional Chinese and Western medicine in treatment of 43 cases of arteriosclerosis obliterans. Xin Zhong Yi. 2008; 40(2): 47-49.
16. Li C, Wen Z. Integrated traditional Chinese and Western medicine in treatment of 28 cases of arteriosclerosis obliterans. Jilin Zhong Yi Yao. 2004; 24(4): 30.
17. Wang CX, Qi QH, Wu XZ. Observation on effect of integrated Chinese and Western medicine in treating patients with peripheral atherosclerosis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999; 19(6): 332-334.
18. Mou X, Ma GL. Clinical research of Wentong Tang in treatment of arteriosclerosis obliterans. Beijing Zhong Yi Za Zhi. 2002; 21(6): 341-343.
19. Wu YQ. Clinical observation of Wenjing Fumai Tang in treatment of 32 cases of arteriosclerosis obliterans in stage II. Beijing Zhong Yi Yao. 2008; 27(6): 453-455.
20. 1 in treatment of lower extremity arteriosclerosis obliterans. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi. 2008; 6(8): 987-988.
21. Wang NM, Zhao XL, Jin ML. Clinical observation of defibrase in treatment of lower extremity arteriosclerosis obliterans. Zhongguo Wu Zhen Xue Za Zhi. 2008; 8(1): 677-678.
22. Wang LM, Wang TN, Zhao HF, Zhang CY. Clinical observation of Chinese herbal medicine in treatment of postoperation of vascular prosthesis by pass for lower extremity arteriosclerosis obliterans. Liaoning Zhong Yi Za Zhi. 2008; 35(5): 729-730.
23. Zhuang BX, Ma LB, Yu CL, Zhang T, Yang S, Shi B, Shi DZ. Effects of Refined Xuefu Capsule on vascular patency rate after femoral-popliteal by pass. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007; 27(1): 69-71.
24. Chan SL, Li SJ, Li SL, Run JM, Liu LH, Sun FQ, Kong HY, Cui MX. Clinical observation of Qizhi Gubu Capsule in treatment of 63 cases of arteriosclerosis obliterans complicated with diabetes. Xin Zhong Yi. 2008; 40(6): 23-24.
25. Mao LH. Integrated traditional Chinese and Western medicine in treatment of 60 cases of arteriosclerosis obliterans complicated with diabetes. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi. 2003; 1(7): 393-394.
26. Han JQ, Zhang YN, Zhao TZ, Zhang JG, Hu SQ, Fang LH. Tripterygium wilfordii in treatment of lower extremity arteriosclerosis obliterans complicated with diabetes. Shi Yong Tang Niao Bing Za Zhi. 2007; 3(1): 50-51.
27. Picquet J, Jacquinandi V, Saumet JL, Leftheriotis G, Enon B, Abraham P. Systematic diagnostic approach to proximal-without-distal claudication in a vascular population. Eur J Intern Med. 2005; 16(8): 575-579. (Pubitemid 41728212)
28. Fu JY. Current status of research on complementary and alternative medicine in the United States: in comparison with that on traditional Chinese medicine in China. J Chin Integr Med. 2008; 6(6): 551-554.
29. Liao X, Xie YM. Application of semi-structured and in-depth interview on optimization of clinical research program in traditional Chinese medicine. J Chin Integr Med. 2009; 7(4): 309-314.
30. Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, Moher D, CONSORT for TCM Group. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) . Zhongguo Xun Zheng Yi Xue Za Zhi. 2007; 7(8): 601-605.